Compendium of Cancer Genome Aberrations

STBT5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 16: Line 16:
!'''Date of Last Editor Review'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
!
!
!
!
!
|-
|-
|[[STBT5:Lipoma|Lipoma]]
|CHAPTER 2 (SOFT TISSUE TUMOURS)
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Lipomatosis|Lipomatosis]]
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|[[STBT5:Lipoma|Lipoma]]
|Disease
|
|
|
|
|-
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
|Disease
|
|
|
|
Line 49: Line 64:
|
|
|
|
|-
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
|Disease
|
|
|
|
|
|
|-
|[[STBT5:Lipomatosis|Lipomatosis]]
|Disease
|
|
|
|
Line 60: Line 75:
|
|
|
|
|-
|[[STBT5:Angiolipoma_|Angiolipoma]]
|Disease
|
|
|
|
Line 72: Line 84:
|
|
|-
|-
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
|Disease
|Disease
|
|
Line 79: Line 91:
|
|
|
|
|
|
|
|-
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
|Disease
|
|
|
|
Line 94: Line 100:
|
|
|-
|-
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
|Disease
|Disease
|
|
Line 104: Line 110:
|
|
|
|
|-
|[[STBT5:Hibernoma|Hibernoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiolipoma_|Angiolipoma]]
|Disease
|
|
|
|
Line 115: Line 123:
|
|
|
|
|-
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
|Disease
|
|
|
|
Line 127: Line 132:
|
|
|-
|-
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
|Disease
|Disease
|
|
Line 137: Line 142:
|
|
|
|
|-
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
|Disease
|
|
|
|
Line 148: Line 155:
|
|
|
|
|-
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
|Disease
|
|
|
|
Line 160: Line 164:
|
|
|-
|-
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
|Disease
|Disease
|
|
Line 170: Line 174:
|
|
|
|
|-
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Hibernoma|Hibernoma]]
|Disease
|
|
|
|
Line 181: Line 187:
|
|
|
|
|-
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
|Disease
|
|
|
|
Line 193: Line 196:
|
|
|-
|-
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
|Disease
|Disease
|
|
Line 203: Line 206:
|
|
|
|
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
|Disease
|
|
|
|
Line 214: Line 219:
|
|
|
|
|-
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|Disease
|
|
|
|
Line 226: Line 228:
|
|
|-
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
|Disease
|Disease
|
|
Line 236: Line 238:
|
|
|
|
|-
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
|Disease
|
|
|
|
Line 247: Line 251:
|
|
|
|
|-
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|Disease
|
|
|
|
Line 259: Line 260:
|
|
|-
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
|Disease
|Disease
|
|
Line 266: Line 267:
|
|
|
|
|
|
|
|-
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|Disease
|
|
|
|
Line 281: Line 276:
|
|
|-
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
|Disease
|Disease
|
|
Line 291: Line 286:
|
|
|
|
|-
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
|Disease
|
|
|
|
Line 302: Line 299:
|
|
|
|
|-
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|Disease
|
|
|
|
Line 314: Line 308:
|
|
|-
|-
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|Disease
|Disease
|
|
Line 324: Line 318:
|
|
|
|
|-
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|Disease
|
|
|
|
Line 335: Line 331:
|
|
|
|
|-
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|Disease
|
|
|
|
Line 347: Line 340:
|
|
|-
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|Disease
|Disease
|
|
Line 357: Line 350:
|
|
|
|
|-
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|Disease
|
|
|
|
Line 368: Line 363:
|
|
|
|
|-
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|Disease
|
|
|
|
Line 380: Line 372:
|
|
|-
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
|Disease
|Disease
|
|
Line 390: Line 382:
|
|
|
|
|-
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|Disease
|
|
|
|
Line 401: Line 395:
|
|
|
|
|-
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|Disease
|
|
|
|
Line 413: Line 404:
|
|
|-
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|Disease
|Disease
|
|
Line 423: Line 414:
|
|
|
|
|-
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|Disease
|
|
|
|
Line 434: Line 427:
|
|
|
|
|-
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|Disease
|
|
|
|
Line 446: Line 436:
|
|
|-
|-
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|Disease
|Disease
|
|
Line 456: Line 446:
|
|
|
|
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Shashi Shetty and Reba Daniel (resident)
|2/21/2024
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|Template added 2/21/2024
|
|
|-
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|Disease
|Disease
|
|
Line 478: Line 462:
|
|
|
|
|-
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|Disease
|
|
|
|
Line 489: Line 475:
|
|
|
|
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|Disease
|
|
|
|
Line 501: Line 484:
|
|
|-
|-
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|Disease
|Disease
|
|
Line 508: Line 491:
|
|
|
|
|
|
|
|-
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|Disease
|
|
|
|
Line 523: Line 500:
|
|
|-
|-
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|Disease
|Disease
|
|
Line 533: Line 510:
|
|
|
|
|-
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|Disease
|
|
|
|
Line 544: Line 523:
|
|
|
|
|-
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|Disease
|
|
|
|
Line 556: Line 532:
|
|
|-
|-
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|Disease
|Disease
|
|
Line 566: Line 542:
|
|
|
|
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|Disease
|
|
|
|
Line 577: Line 555:
|
|
|
|
|-
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|Disease
|
|
|
|
Line 589: Line 564:
|
|
|-
|-
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|Disease
|Disease
|
|
Line 596: Line 571:
|
|
|
|
|
|
|
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|Disease
|
|
|
|
Line 611: Line 580:
|
|
|-
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|Disease
|Disease
|
|
Line 621: Line 590:
|
|
|
|
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|Disease
|
|
|
|
Line 632: Line 603:
|
|
|
|
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|Disease
|
|
|
|
Line 644: Line 612:
|
|
|-
|-
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|Disease
|Disease
|
|
Line 654: Line 622:
|
|
|
|
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|Disease
|
|
|
|
Line 665: Line 635:
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|Disease
|
|
|
|
Line 677: Line 644:
|
|
|-
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|Disease
|Disease
|
|
Line 687: Line 654:
|
|
|
|
|-
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|Disease
|
|
|
|
Line 698: Line 667:
|
|
|
|
|-
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|Disease
|
|
|
|
Line 710: Line 676:
|
|
|-
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|Disease
|Disease
|
|
Line 717: Line 683:
|
|
|
|
|
|
|
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|
|
|
|
Line 732: Line 692:
|
|
|-
|-
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Disease
|Shashi Shetty and Reba Daniel (resident)
|2/21/2024
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|Template added 2/21/2024
|
|
|
|
Line 743: Line 708:
|
|
|-
|-
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|Disease
|
|
Line 750: Line 715:
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|Disease
|
|
|
|
Line 765: Line 724:
|
|
|-
|-
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 776: Line 740:
|
|
|-
|-
|[[STBT5:Glomus_tumour|Glomus tumour]]
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|Disease
|Disease
|
|
Line 786: Line 750:
|
|
|
|
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|Disease
|
|
|
|
Line 797: Line 763:
|
|
|
|
|-
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|Disease
|
|
|
|
Line 809: Line 772:
|
|
|-
|-
|[[STBT5:Leiomyoma|Leiomyoma]]
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|Disease
|Disease
|
|
Line 819: Line 782:
|
|
|
|
|-
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|Disease
|
|
|
|
Line 830: Line 795:
|
|
|
|
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|Disease
|
|
|
|
Line 842: Line 804:
|
|
|-
|-
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 853: Line 820:
|
|
|-
|-
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|Disease
|Disease
|
|
Line 863: Line 830:
|
|
|
|
|-
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|Disease
|
|
|
|
Line 874: Line 843:
|
|
|
|
|-
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|Disease
|
|
|
|
Line 886: Line 852:
|
|
|-
|-
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|Disease
|Disease
|
|
Line 896: Line 862:
|
|
|
|
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|Disease
|
|
|
|
Line 907: Line 875:
|
|
|
|
|-
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|Disease
|
|
|
|
Line 919: Line 884:
|
|
|-
|-
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 930: Line 900:
|
|
|-
|-
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|Disease
|Disease
|
|
Line 940: Line 910:
|
|
|
|
|-
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|Disease
|
|
|
|
Line 951: Line 923:
|
|
|
|
|-
|[[STBT5:Schwannoma|Schwannoma]]
|Disease
|
|
|
|
Line 963: Line 932:
|
|
|-
|-
|[[STBT5:Neurofibroma|Neurofibroma]]
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|Disease
|Disease
|
|
Line 973: Line 942:
|
|
|
|
|-
|[[STBT5:Perineurioma|Perineurioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|Disease
|
|
|
|
Line 984: Line 955:
|
|
|
|
|-
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|
|
|
|
Line 996: Line 964:
|
|
|-
|-
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 1,007: Line 980:
|
|
|-
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|Disease
|Disease
|
|
Line 1,017: Line 990:
|
|
|
|
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|Disease
|
|
|
|
Line 1,028: Line 1,003:
|
|
|
|
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|Disease
|
|
|
|
Line 1,040: Line 1,012:
|
|
|-
|-
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|Disease
|
|
Line 1,050: Line 1,022:
|
|
|
|
|-
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|Disease
|
|
|
|
Line 1,061: Line 1,035:
|
|
|
|
|-
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|
|
|
|
Line 1,073: Line 1,044:
|
|
|-
|-
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 1,084: Line 1,060:
|
|
|-
|-
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|Disease
|Disease
|
|
Line 1,094: Line 1,070:
|
|
|
|
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|
|
|
|
Line 1,105: Line 1,083:
|
|
|
|
|-
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|
|
|
|
Line 1,117: Line 1,092:
|
|
|-
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|Disease
|
|
Line 1,127: Line 1,102:
|
|
|
|
|-
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|Disease
|
|
|
|
Line 1,138: Line 1,115:
|
|
|
|
|-
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|Disease
|
|
|
|
Line 1,150: Line 1,124:
|
|
|-
|-
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|Disease
|Disease
|
|
Line 1,160: Line 1,134:
|
|
|
|
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|Disease
|
|
|
|
Line 1,171: Line 1,147:
|
|
|
|
|-
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|Disease
|
|
|
|
Line 1,183: Line 1,156:
|
|
|-
|-
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|[[STBT5:Glomus_tumour|Glomus tumour]]
|Disease
|Disease
|James Solomon, MD, PhD
|2/20/2022
|
|
|PENDING
|
|
|Alanna Church
|
|
|
|
|-
|
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|
|
|
|
Line 1,205: Line 1,172:
|
|
|-
|-
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|Disease
|Disease
|
|
Line 1,215: Line 1,182:
|
|
|
|
|-
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|Disease
|
|
|
|
Line 1,226: Line 1,195:
|
|
|
|
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|Disease
|
|
|
|
Line 1,238: Line 1,204:
|
|
|-
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|[[STBT5:Leiomyoma|Leiomyoma]]
|Disease
|Disease
|
|
Line 1,248: Line 1,214:
|
|
|
|
|-
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|Disease
|
|
|
|
Line 1,259: Line 1,227:
|
|
|
|
|-
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|Disease
|
|
|
|
Line 1,271: Line 1,236:
|
|
|-
|-
|[[STBT5:PEComa|PEComa]]
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|Disease
|Disease
|
|
Line 1,281: Line 1,246:
|
|
|
|
|-
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|Disease
|
|
|
|
Line 1,292: Line 1,259:
|
|
|
|
|-
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|Disease
|
|
|
|
Line 1,304: Line 1,268:
|
|
|-
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|Disease
|Disease
|Sadeem Qdaisat
|10/1/23
|
|
|PENDING
|
|
|Working with Eric McGinnis
|
|
|2021 template added
|
|-
|
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|Disease
|
|
|
|
Line 1,326: Line 1,284:
|
|
|-
|-
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 1,336: Line 1,294:
|
|
|
|
|-
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|Disease
|
|
|
|
Line 1,347: Line 1,307:
|
|
|
|
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|Disease
|
|
|
|
Line 1,359: Line 1,316:
|
|
|-
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 1,366: Line 1,323:
|
|
|
|
|
|
|
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|Disease
|
|
|
|
Line 1,381: Line 1,332:
|
|
|-
|-
|[[STBT5:Enchondroma|Enchondroma]]
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 1,388: Line 1,339:
|
|
|
|
|
|
|
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|Disease
|
|
|
|
Line 1,403: Line 1,348:
|
|
|-
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|Disease
|Disease
|
|
Line 1,413: Line 1,358:
|
|
|
|
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|Disease
|
|
|
|
Line 1,424: Line 1,371:
|
|
|
|
|-
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|Disease
|
|
|
|
Line 1,436: Line 1,380:
|
|
|-
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|Disease
|Disease
|
|
Line 1,446: Line 1,390:
|
|
|
|
|-
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|Disease
|
|
|
|
Line 1,457: Line 1,403:
|
|
|
|
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|
|
|
|
Line 1,469: Line 1,412:
|
|
|-
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|[[STBT5:Schwannoma|Schwannoma]]
|Disease
|Disease
|
|
Line 1,479: Line 1,422:
|
|
|
|
|-
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Neurofibroma|Neurofibroma]]
|Disease
|
|
|
|
Line 1,490: Line 1,435:
|
|
|
|
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|Disease
|
|
|
|
Line 1,502: Line 1,444:
|
|
|-
|-
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|[[STBT5:Perineurioma|Perineurioma]]
|Disease
|Disease
|
|
Line 1,512: Line 1,454:
|
|
|
|
|-
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|
|
|
|
Line 1,523: Line 1,467:
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|Disease
|
|
|
|
Line 1,535: Line 1,476:
|
|
|-
|-
|[[STBT5:Osteoma|Osteoma]]
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|Disease
|Disease
|
|
Line 1,545: Line 1,486:
|
|
|
|
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|Disease
|
|
|
|
Line 1,556: Line 1,499:
|
|
|
|
|-
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|
|
|
|
Line 1,568: Line 1,508:
|
|
|-
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|Disease
|Disease
|
|
Line 1,578: Line 1,518:
|
|
|
|
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|Disease
|
|
|
|
Line 1,589: Line 1,531:
|
|
|
|
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|
|
|
|
Line 1,601: Line 1,540:
|
|
|-
|-
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|Disease
|Disease
|
|
Line 1,611: Line 1,550:
|
|
|
|
|-
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|
|
|
|
Line 1,622: Line 1,563:
|
|
|
|
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|
|
|
|
Line 1,634: Line 1,572:
|
|
|-
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|Disease
|
|
Line 1,641: Line 1,579:
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|
|
|
|
Line 1,656: Line 1,588:
|
|
|-
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|Disease
|Disease
|
|
Line 1,666: Line 1,598:
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|Disease
|
|
|
|
Line 1,677: Line 1,611:
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|
|
|
|
Line 1,689: Line 1,620:
|
|
|-
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|Disease
|Disease
|
|
Line 1,699: Line 1,630:
|
|
|
|
|-
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|
|
|
|
Line 1,710: Line 1,643:
|
|
|
|
|-
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|
|
|
|
Line 1,722: Line 1,652:
|
|
|-
|-
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 1,732: Line 1,662:
|
|
|
|
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|Disease
|
|
|
|
Line 1,743: Line 1,675:
|
|
|
|
|-
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|
|
|
|
Line 1,755: Line 1,684:
|
|
|-
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|Disease
|Disease
|
|
Line 1,765: Line 1,694:
|
|
|
|
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|Disease
|
|
|
|
Line 1,776: Line 1,707:
|
|
|
|
|-
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|
|
|
|
Line 1,788: Line 1,716:
|
|
|-
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|Disease
|Disease
|
|
Line 1,798: Line 1,726:
|
|
|
|
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|Disease
|
|
|
|
Line 1,809: Line 1,739:
|
|
|
|
|-
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|
|
|
|
Line 1,821: Line 1,748:
|
|
|-
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|Disease
|James Solomon, MD, PhD
|2/20/2022
|
|
|PENDING
|
|Alanna Church
|
|
|
|
Line 1,832: Line 1,764:
|
|
|-
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|Disease
|
|
Line 1,842: Line 1,774:
|
|
|
|
|-
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|Disease
|
|
|
|
Line 1,853: Line 1,787:
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|
|
|
|
Line 1,865: Line 1,796:
|
|
|-
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|Disease
|Disease
|
|
Line 1,875: Line 1,806:
|
|
|
|
|-
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|Disease
|
|
|
|
Line 1,886: Line 1,819:
|
|
|
|
|-
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|
|
|
|
Line 1,898: Line 1,828:
|
|
|-
|-
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,908: Line 1,838:
|
|
|
|
|-
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|
|
|
|
Line 1,919: Line 1,851:
|
|
|
|
|-
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|Disease
|
|
|
|
Line 1,931: Line 1,860:
|
|
|-
|-
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|Disease
|Disease
|
|
Line 1,941: Line 1,870:
|
|
|
|
|-
|[[STBT5:Enchondromatosis|Enchondromatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:PEComa|PEComa]]
|Disease
|
|
|
|
Line 1,952: Line 1,883:
|
|
|
|
|-
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|
|
|
|
Line 1,964: Line 1,892:
|
|
|-
|-
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|Disease
|Disease
|
|
Line 1,973: Line 1,901:
|
|
|
|
|
|
|-
|
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
|
|Disease
|
|
|
|-
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
Line 1,986: Line 1,924:
|
|
|-
|-
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|
|Disease
|
|
|
|
|
|
|
|
|
|
Line 1,997: Line 1,940:
|
|
|-
|-
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Disease
|Sadeem Qdaisat
|10/1/23
|
|
|PENDING
|
|
|Working with Eric McGinnis
|
|
|2021 template added
|
|
|
|
Line 2,008: Line 1,956:
|
|
|-
|-
|[[STBT5:Werner_syndrome|Werner syndrome]]
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Enchondroma|Enchondroma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteoma|Osteoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Enchondromatosis|Enchondromatosis]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Werner_syndrome|Werner syndrome]]
|Disease
|
|
|
|
|
|
|
|
|
Retrieved from "https://test.ccga.io/index.php/STBT5:Volunteer_Assignments_and_Opportunities"